The FDA Fast Track program is a regulatory initiative by the U.S. Food and Drug Administration to accelerate the development and review of drugs for serious or life-threatening conditions. It is intended for therapies that address unmet medical needs, allowing for more frequent communication with the FDA and eligibility for priority review. This process helps bring important treatments to market more quickly, benefiting patients and healthcare providers.